Natural Biocon (India) Ltd
₹ 4.27
6.75%
04 Mar
- close price
About
Incorporated in 1992, Natural Biocon Ltd is engaged in the trading of agricultural
produce.[1]
Key Points
- Market Cap ₹ 11.0 Cr.
- Current Price ₹ 4.27
- High / Low ₹ 16.0 / 3.55
- Stock P/E
- Book Value ₹ 12.4
- Dividend Yield 0.00 %
- ROCE 0.27 %
- ROE 0.18 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 0.34 times its book value
- Company's working capital requirements have reduced from 66.1 days to 14.9 days
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- Promoter holding is low: 9.36%
- Company has a low return on equity of 0.79% over last 3 years.
- Company has high debtors of 247 days.
- Promoter holding has decreased over last 3 years: -11.9%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Fertilizers & Agrochemicals Pesticides & Agrochemicals
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.05 | 0.15 | 1.04 | 0.45 | 0.00 | 0.13 | 0.48 | 1.25 | 13.53 | 8.35 | 3.02 | |
| 0.05 | 0.04 | 0.04 | 0.34 | 0.03 | 0.13 | 0.39 | 1.00 | 13.30 | 8.29 | 3.45 | |
| Operating Profit | 0.00 | 0.11 | 1.00 | 0.11 | -0.03 | 0.00 | 0.09 | 0.25 | 0.23 | 0.06 | -0.43 |
| OPM % | 0.00% | 73.33% | 96.15% | 24.44% | 0.00% | 18.75% | 20.00% | 1.70% | 0.72% | -14.24% | |
| 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.00 | 0.11 | 1.00 | 0.12 | -0.03 | 0.00 | 0.09 | 0.25 | 0.23 | 0.06 | -0.43 |
| Tax % | 27.27% | 30.00% | 41.67% | 166.67% | 22.22% | 28.00% | 30.43% | 33.33% | |||
| 0.00 | 0.08 | 0.70 | 0.07 | -0.08 | 0.00 | 0.07 | 0.18 | 0.15 | 0.04 | -0.43 | |
| EPS in Rs | 0.00 | 0.07 | 0.62 | 0.06 | -0.07 | 0.00 | 0.06 | 0.16 | 0.13 | 0.02 | -0.18 |
| Dividend Payout % | 0.00% | 0.00% | 81.21% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 159% |
| TTM: | -84% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 20% |
| 3 Years: | -17% |
| TTM: | -170% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | -23% |
| 3 Years: | -5% |
| 1 Year: | -67% |
| Return on Equity | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 1% |
| 3 Years: | 1% |
| Last Year: | 0% |
Balance Sheet
Figures in Rs. Crores
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 11.37 | 11.37 | 11.37 | 11.37 | 11.37 | 11.37 | 11.37 | 11.37 | 11.37 | 25.78 | 25.78 |
| Reserves | 0.00 | 0.01 | 0.64 | 0.64 | 0.61 | 0.61 | 0.68 | 0.86 | 1.01 | 6.09 | 6.18 |
| 0.00 | 0.00 | 0.00 | 0.82 | 0.68 | 0.36 | 0.16 | 0.15 | 0.07 | 0.28 | 0.18 | |
| 0.03 | 0.13 | 0.42 | 0.19 | 0.05 | 0.04 | 0.08 | 1.13 | 4.32 | 6.37 | 6.66 | |
| Total Liabilities | 11.40 | 11.51 | 12.43 | 13.02 | 12.71 | 12.38 | 12.29 | 13.51 | 16.77 | 38.52 | 38.80 |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 | 0.02 | |
| CWIP | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 21.12 | 21.12 |
| 8.11 | 8.22 | 9.14 | 9.73 | 9.42 | 9.09 | 8.99 | 10.21 | 13.47 | 14.11 | 14.37 | |
| Total Assets | 11.40 | 11.51 | 12.43 | 13.02 | 12.71 | 12.38 | 12.29 | 13.51 | 16.77 | 38.52 | 38.80 |
Cash Flows
Figures in Rs. Crores
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.04 | 0.21 | -0.04 | -0.86 | 0.15 | 0.32 | 0.18 | 0.21 | -0.12 | 1.30 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 | -21.11 | |
| 0.00 | -0.07 | -0.07 | 0.75 | -0.14 | -0.32 | 0.00 | -0.02 | -0.09 | 19.67 | |
| Net Cash Flow | 0.04 | 0.15 | -0.11 | -0.11 | 0.01 | 0.00 | 0.17 | 0.19 | -0.21 | -0.14 |
Ratios
Figures in Rs. Crores
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | 0.00 | 357.98 | 632.67 | 1,460.00 | 372.60 | 183.96 | 131.38 | 247.41 | |
| Inventory Days | 821.25 | 547.50 | 381.59 | 4.61 | 8.40 | |||||
| Days Payable | 0.00 | 0.00 | 423.07 | 117.92 | 270.17 | |||||
| Cash Conversion Cycle | 821.25 | 547.50 | 357.98 | 632.67 | 1,460.00 | 372.60 | 142.48 | 18.07 | -14.36 | |
| Working Capital Days | 7,665.00 | 2,238.67 | 572.07 | 681.33 | 3,818.46 | 357.40 | 134.32 | 49.10 | 14.86 | |
| ROCE % | 0.97% | 8.55% | 0.97% | -0.24% | 0.00% | 0.73% | 2.03% | 1.85% | 0.27% |
Insights
In beta| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| Inventory (Stock-in-Trade) INR Lacs |
|
|||||||
| Number of Permanent Employees count |
||||||||
| Purchase of Stock-in-Trade INR Lacs |
||||||||
| Revenue from Operations (Gross Sales) INR Lacs |
||||||||
| Transportation Expenses INR Lacs |
||||||||
| Trade Receivables Turnover Ratio times |
||||||||
| Trade Payables Turnover Ratio times |
||||||||
Requires Premium
Requires Premium
Documents
Announcements
- Un-Audited Financial Results (UFR) For The Third Quarter And Nine Months Ended December 31, 2025, Along With The Statutory Auditors' Limited Review Report. 13 Feb
-
Board Meeting Outcome for Un-Audited Financial Results (UFR) For The Third Quarter And Nine Months Ended December 31, 2025, Along With The Statutory Auditors' Limited Review Report.
13 Feb - Board approved Q3/9M unaudited results on Feb 13, 2026: Q3 loss Rs4.27L, YTD profit Rs5.23L.
-
Board Meeting Intimation for Unaudited Financial Result For The Third Quarter Ended On 31St December, 2025 Along With The Auditor''s Limited Review Report.
9 Feb - Board meeting on 13 Feb 2026 to approve unaudited Q3 results for quarter ended 31 Dec 2025.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
8 Jan - Certificate under Reg 74(5) of SEBI for quarter ended on December 31, 2025
- Closure of Trading Window 26 Dec 2025
Business Overview:[1][2]
NBL is engaged in the business of agricultural activities, which deals in extracting, processing,
and manufacturing agrochemicals and natural alkaloids—like nicotine, caffeine, morphine, and others—from plants, seeds, and agricultural produce. It also deals in barley malt, maltose,
malt sugar, and their derivatives, with operations covering import, export, procurement, assembly, and trade of these products.